# China NMPA Drug Inspection - Hebei Jiheng Pharmaceutical Co., Ltd. - safflower

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hebei-jiheng-pharmaceutical-co-ltd/1bce8b90-abb7-4313-bab7-d329bddbcc2c/
Source feed: China

> China NMPA drug inspection for Hebei Jiheng Pharmaceutical Co., Ltd. published January 12, 2017. Drug: safflower. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement No. 5 of 2017 from the State Administration for Market Regulation on the Results of Special Sampling Inspections of Chinese Medicinal Herbs and Prepared Slices
- Company Name: Hebei Jiheng Pharmaceutical Co., Ltd.
- Publication Date: 2017-01-12
- Drug Name: safflower
- Inspection Finding: Acid Red 73, Carmine, Tartrazine, Orange II, or Sunset Yellow were detected, indicating staining problems. In addition, some batches of products also had issues with appearance, identification, impurities, or content determination that did not meet the standard requirements.
- Action Taken: We have taken timely and lawful measures to control the products, including sealing and seizing, suspending production and sales, and requiring companies to voluntarily recall their products. We have also filed cases against the relevant companies and units for investigation and punishment.

Company: https://www.globalkeysolutions.net/companies/hebei-jiheng-pharmaceutical-co-ltd/40c13de7-1cae-4843-9d4c-724d0f085ce7/